🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Anticoagulation

Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation NCT06275555NA1 site📍 Beijing Xiaotong Hou · Tests: bivalirudin, unfractionated heparin LAAO Versus NOAC in Patients with AF and PCI NCT05353140NA1 site📍 Xi'an Xijing Hospital · Tests: The WATCHMAN/WATCHMAN FLX device, Rivaroxaban + Clopidogre, Aspirin + Clopidogrel Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) NCT03297281NA1 site📍 Toulouse Clinique Pasteur · Tests: Maintenance of OAC in surgery of BPH by PVP., Discontinuation of OAC in surgery of BPH by PVP. Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients NCT05410275Phase 32 sites📍 Tours📍 Tours University Hospital, Tours · Tests: Rivaroxaban Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants NCT06823466n/a47 sites📍 Zagreb📍 Copenhagen📍 Asyut University of L'Aquila Anticoagulation and Inflammation Monitoring in Patients After Heart and Vascular Interventions NCT06222866n/a1 site📍 Innsbruck Medical University Innsbruck · Tests: Anticoagulation monitoring DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis NCT05701917NA64 sites📍 Scottsdale📍 Tucson📍 Orange Inari Medical · Tests: ClotTriever System, Commercially available/market approved anticoagulation medication including but not limited to: Hep… Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention NCT04977076NA1 site📍 Heerlen Zuyderland Medisch Centrum · Tests: Uninterrupted DOAC use, Interrupted DOAC use Cangrelor on Top of anticoagUlation in Patients With myocaRdial Infarction-related Cardiogenic Shock/Cardiac Arrest receiVIng VA-ECMO NCT06792643Phase 21 site📍 Milan IRCCS San Raffaele · Tests: Cangrelor Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake NCT06571149Phase 4109 sites📍 Eisenstadt📍 Graz📍 Innsbruck Insel Gruppe AG, University Hospital Bern · Tests: Tenecteplase or Alteplase The PERSEVERE Study NCT06588634NA33 sites📍 New Haven📍 Orlando📍 Orlando Inari Medical · Tests: FlowTriever System, Standard of Care Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study) NCT07372716NA1 site📍 Ottawa Ottawa Hospital Research Institute · Tests: standardized perioperative anticoagulation management Guideline Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation NCT06871228NA22 sites📍 Hefei📍 Beijing📍 Guangzhou Beijing Anzhen Hospital · Tests: NOAC discontinuation, NOAC continuation, Smartwatch single-lead ECG monitoring Optimizing Anticoagulation in Pregnancies With Mechanical Heart Valves NCT07658989NA1 site📍 Toronto Mount Sinai Hospital, Canada · Tests: LMWH and LDA, Vitamin K antagonists (e.g warfarin)+/- LDA, Sequential therapy +/- LDA Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department NCT06692504n/a1 site📍 Besançon Centre Hospitalier Universitaire de Besancon Anticoagulation Combined With Tocilizumab for Interleukin-6 Receptor Inhibition in Acute Cerebral Venous Thrombosis NCT07801638NA1 site📍 Beijing Capital Medical University · Tests: Tocilizumab, Standard Treatment COOLEY- Study: aCute On chrOnic Liver failurE Using the cYtosorb Device NCT06079021NA1 site📍 Edegem University Hospital, Antwerp · Tests: CytoSorb Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia NCT02735707Phase 3408 sites📍 Jacksonville📍 Augusta📍 Chicago UMC Utrecht · Tests: Ceftriaxone, Moxifloxacin or Levofloxacin, Piperacillin-tazobactam, Ceftaroline, Amoxicillin-clavulanate Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG NCT04045665Phase 3106 sites📍 Little Rock📍 Los Angeles📍 Los Angeles Icahn School of Medicine at Mount Sinai · Tests: Antiplatelet-only strategy, Oral Anticoagulant plus background antiplatelet therapy MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis NCT07548346NA14 sites📍 Alexandria📍 Cairo📍 Cairo Middle East North Africa Stroke and Interventional Neurothe… · Tests: Endovascular Thrombectomy, Anticoagulation Therapy Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation NCT06954610n/a1 site📍 Bern Insel Gruppe AG, University Hospital Bern · Tests: No intervention Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support NCT06442267Phase 41 site📍 Vienna Medical University of Vienna · Tests: Enoxaparin Injectable Solution, Argatroban, 1 Mg/mL Intravenous Solution, Unfractionated heparin Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study NCT05089227Phase 21 site📍 Dijon Centre Hospitalier Universitaire Dijon · Tests: treatment "intervention", treatment "standard", biological assessment Efficacy and Safety of Citrate Anticoagulation in CRRT for Patients With Liver Failure/DysfuncTION, the CAUTION Trial! A Retrospective Study on Etiology of Liver Failure and Their Complications NCT06908746n/a1 site📍 Edegem University Hospital, Antwerp Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation NCT06868823n/a1 site📍 Prague University Hospital, Motol Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial NCT06523959Phase 41 site📍 Helsinki Clinical Urology and Epidemiology Working Group · Tests: Apixaban 2.5 MG Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT NCT05399537Phase 314 sites📍 Birmingham📍 Los Angeles📍 Los Angeles Vantive Health LLC · Tests: Prismocitrate 18, PrisMax System Version 3.x with calcium line accessory Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH) NCT04861103Phase 41 site📍 Orange University of California, Irvine · Tests: Lovenox Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure NCT06957366NA14 sites📍 Hartford📍 Evanston📍 Boston McMaster University · Tests: PAUSE Perioperative DOAC Management, ASRA Perioperative DOAC Management Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism NCT07399977NA8 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: MSK-ACCESS, ctDNA/VTE Risk Score:
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy